GC Biopharma brings its proven legacy of excellence in plasma technology to the US through GC Biopharma USA, Inc. Headquartered in Teaneck, NJ, GC Biopharma USA extends our expertise and commitment as a global leader. We have recently launched our next-generation IVIG 10% liquid formulation, ALYGLO™ (Immune Globulin Intravenous, Human-stwk) for Adults- 17 and older, with Primary Humoral Immunodeficiency (PI). As our business grows, we are committed to meeting our customers' needs and building a platform dedicated to our mission and vision.
MISSION
Devoted to improving the healthy lives of people
VISION
A global leader in the healthcare industry
GC Biopharma specializes in rare disease drugs and is one of the top pharmaceutical manufacturers of plasma products, which are distributed in more than 50 countries.
Our past success is the foundation of our future.